An open-label pilot study of N-acetylcysteine for skin-picking in Prader-Willi syndrome

American Journal of Medical Genetics, Part A

Volumn 164, Issue 2, 2014, Pages 421-424

  Miller, Jennifer L ^a   Angulo, Moris ^b  

^a UNIVERSITY OF FLORIDA   (United States)

^b WINTHROP UNIVERSITY HOSPITAL   (United States)

Author keywords

N acetylcysteine; Prader Willi syndrome; Skin picking

Indexed keywords

ACETYLCYSTEINE; GLUTATHIONE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

ADOLESCENT; ADULT; ADVERSE OUTCOME; ARTICLE; AUTOMUTILATION; CHILD; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DIARRHEA; DISEASE SEVERITY; DRUG EFFICACY; FEMALE; FLATULENCE; GASTROINTESTINAL SYMPTOM; GENE DELETION; HUMAN; MALE; MUSCLE CRAMP; NEUROMODULATION; OPEN STUDY; OUTCOME ASSESSMENT; PILOT STUDY; PRADER WILLI SYNDROME; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SKIN DEFECT; SKIN DISEASE; SKIN PICKING; UNIPARENTAL DISOMY; YOUNG ADULT;

N-ACETYLCYSTEINE; PRADER-WILLI SYNDROME; SKIN-PICKING;

ACETYLCYSTEINE; ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; MALE; PILOT PROJECTS; PRADER-WILLI SYNDROME; SELF MUTILATION; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84892893861     PISSN: 15524825     EISSN: 15524833     Source Type: Journal    
DOI: 10.1002/ajmg.a.36306     Document Type: Article

References (24)

1. Amrouche-Mekkioui I, Djerdjouri B. 2012. N-acetylcysteine improves redox status, mitochondrial dysfunction, mucin-depleted crypts and epithelial hyperplasia in dextran sulfate sodium-induced oxidative colitis in mice. Eur J Pharmacol 691:209-217.
2. Asevedo E, Cunha GR, Zugman A, Mansur RB, Brietzke E. 2012. N-acetylcysteine as a potentially useful medication to prevent conversion to schizophrenia in at-risk individuals. Rev Neurosci 23:353-362.
3. Banga A, Connor DF. 2012. Effectiveness of naltrexone for treating pathologic skin picking behavior in an adolescent with Prader-Willi syndrome. J Child Adolesc Psychopharmacol 22:396-398.
4. Berk M, Dean O, Cotton SM, Gama CS, Kapczinski F, Fernandes BS, Kohlmann K, Jeavons S, Hewitt K, Allwang C, Cobb H, Bush AI, Schapkaitz I, Dodd S, Malhi GS. 2011. The efficacy of N-acetylcysteine as an adjunctive treatment in bipolar depression: An open label trial. J Affect Disord 135:389-394.
5. Butler MG, Fischer W, Kibiryeva N, Bittel DC. 2008. Array comparative genomic hybridization (aCGH) analysis in Prader-Willi syndrome. Am J Med Genet Part A 146A:854-860.
6. Cao L, Li L, Zuo Z. 2012. N-acetylcysteine reverses existing cognitive impairment and increased oxidative stress in glutamate transporter type 3 deficient mice. Neuroscience 220:85-89.
7. Cassidy SB, Driscoll DJ. 2009. Prader-Willi syndrome. Eur J Hum Genet 17:3-13.
8. Dykens EM, Leckman JF, Cassidy SB. 1996. Obsessions and compulsions in Prader-Willi syndrome. J Child Psychol Psychiatry 37:995-1002.
9. Egashira N, Shirakawa A, Abe M, Niki T, Mishima K, Iwasaki K, Oishi R, Fujiwara M. 2012. N-acetyl-l-cysteine inhibits marble-burying behavior in mice. J Pharmacol Sci 119:97-101.
10. Grant JE, Kim SW, Odlaug BL. 2007. N-acetyl cysteine, a glutamate-modulating agent, in the treatment of pathological gambling: A pilot study. Biol Psychiatry 62:652-657.
11. Grant JE, Odlaug BL, Kim SW. 2009. N-acetylcysteine, a glutamate modulator, in the treatment of trichotillomania: A double-blind, placebo-controlled study. Arch Gen Psychiatry 66:756-763.
12. Hardan AY, Fung LK, Libove RA, Obukhanych TV, Nair S, Herzenberg LA, Frazier TW, Tirouvanziam R. 2012. A randomized controlled pilot trial of oral N-acetylcysteine in children with autism. Biol Psychiatry 71:956-961.
13. Hoffman KL. 2011. Animal models of obsessive compulsive disorder: Recent findings and future directions. Expert Opin Drug Discov 6:725-737.
14. Morgan JR, Storch EA, Woods DW, Bodzin D, Lewin AB, Murphy TK. 2010. A preliminary analysis of the phenomenology of skin-picking in Prader-Willi syndrome. Child Psychiatry Hum Dev 41:448-463.
15. Ramirez-Niño AM, D'Souza MS, Markou A. 2013. N-acetylcysteine decreased nicotine self-administration and cue-induced reinstatement of nicotine seeking in rats: Comparison with the effects of N-acetylcysteine on food responding and food seeking. Psychopharmacology (Berl) 225:473-482.
16. Robinson RA, Joshi G, Huang Q, Sultana R, Baker AS, Cai J, Pierce W, St Clair DK, Markesbery WR, Butterfield DA. 2011. Proteomic analysis of brain proteins in APP/PS-1 human double mutant knock-in mice with increasing amyloid β-peptide deposition: Insights into the effects of in vivo treatment with N-acetylcysteine as a potential therapeutic intervention in mild cognitive impairment and Alzheimer's disease. Proteomics 11:4243-4256.
17. Rodrigues-Barata AR, Tosti A, Rodríguez-Pichardo A, Camacho-Martínez F. 2012. N-acetylcysteine in the treatment of trichotillomania. Int J Trichol 4:176-178.
18. Schmaal L, Veltman DJ, Nederveen A, van den Brink W, Goudriaan AE. 2012. N-acetylcysteine normalizes glutamate levels in cocaine-dependent patients: A randomized crossover magnetic resonance spectroscopy study. Neuropsychopharmacology 37:2143-2152.
19. Shapira NA, Lessig MC, Murphy TK, Driscoll DJ, Goodman WK. 2002. Topiramate attenuates self-injurious behaviour in Prader-Willi Syndrome. Int J Neuropsychopharmacol 5:141-145.
20. Shungu DC. 2012. N-acetylcysteine for the treatment of glutathione deficiency and oxidative stress in schizophrenia. Biol Psychiatry 71:937-938.
21. Simpson HB, Shungu DC, Bender J Jr, Mao X, Xu X, Slifstein M, Kegeles LS. 2012. Investigation of cortical glutamate-glutamine and γ-aminobutyric acid in obsessive-compulsive disorder by proton magnetic resonance spectroscopy. Neuropsychopharmacology 37:2684-2692.
22. Srikanth K, Pereira E, Duarte AC, Ahmad I. 2013. Glutathione and its dependent enzymes' modulatory responses to toxic metals and metalloids in fish-a review. Environ Sci Pollut Res Pease provide the volume number and page range.Int
23. Symons FJ, Butler MG, Sanders MD, Feurer ID, Thompson T. 1999. Self-injurious behavior and Prader-Willi syndrome: Behavioral forms and body locations. Am J Ment Retard 104:260-269.
24. Uraz S, Tahan G, Aytekin H, Tahan V. 2013. N-acetylcysteine expresses powerful anti-inflammatory and antioxidant activities resulting in complete improvement of acetic acid-induced colitis in rats. Scand J Clin Lab Invest 73:61-66.